The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
Peter Nash
Steering Committee Member
Peter Nash is a Professor in the School of Medicine at Griffith University, Queensland, AU, and Director of the Rheumatology Research Unit on the Sunshine Coast.
The Rheumatology Research Unit, has been involved in many clinical trials involving all modern biologic and targeted synthetic therapies for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus, and osteoporosis, and it has a particular interest in novel therapeutics and Caravaggio. Professor Nash is currently involved in clinical research for a number of novel therapeutics in psoriatic arthritis. He is also a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) steering committee.
Filter by content: